Live Breaking News & Updates on Reflux pharmaceuticals

Eiko Lifesciences touches roof on inking pact to acquire 25.01% stake in Reflux Pharmaceuticals

Eiko Lifesciences is currently trading at upper circuit limit of Rs. 74.60, up by 3.55 points or 5.00% from its previous closing of Rs. 71.05 on the BSE. The scrip opened at Rs. 73.98 and has touched a high and low of Rs. 74.60 and Rs. 73.00 respectively. So far 58227 shares were traded on

India , Eiko-lifesciences , Reflux-pharmaceuticals , Share-subscription-agreement , Active-pharma-ingredients , Speciality-chemicals , Active-pharmaceutical , Tolfenamic-acid , Pharma-intermediates ,